Our Mission
SynBioVen is a new investment vehicle launched in early 2022 focused on supporting the next generation of synthetic biology scientists, founders and start-ups.
We believe that synthetic biology will drive the next industrial revolution and the transition to a net-zero economy, with UK companies playing a leading role.
Our unique offering
We support you right from the start
We invest early
We support exciting ideas and teams with PoC, pre-seed and seed funding.
Access to experts
From deep-tech to BD - we have you covered
Our team combines expertise in synthetic biology research,
business development and financing - ready to accelerate your journey.
Access to R&D Hub in West London
We help you de-risk and scale
Our companies enjoy support from our dedicated tech team
at SynbiCITE and access to the London Biofoundry.
Our Portfolio
Colorifix
Bringing color to life
Colorifix has developed a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact in a cost-effective manner. Using synthetic biology they produce, deposit and fix dyes biologically, avoiding harmful chemicals whilst reducing water & energy consumption and waste.
https://colorifix.com/
Scindo
Enzymes to the rescue
Scindo develop a novel biological platform to turn low-value plastic landfill waste into high-value molecules.
https://scindo.bio/
Eden Bio
ML-driven strain engineering
Eden Bio apply their powerful machine learning tools to guide genetic engineering of microorganisms for enhanced productivity.
https://eden.bio/
Multus
Scaling cellular agriculture
Multus develop key ingredients for the affordable scale up of cellular agriculture.
https://www.multus.bio
Resurrect bio
Helping crops defeat disease
Resurrect bio invent novel technologies to enhance the immune system of crops for improved protection against disease.
https://resurrect.bio
Chain Biotech
Microbiome therapeutics
Chain creates novel vaccines and immuno-therapies leveraging their unqiue expertise in engineering Clostridia.
https://chainbiotech.com
Valink Therapeutics
Modular platform for antibody development
Valink uses "building block" protein technologies to rapidly build and test libraries of drug candidates.
https://www.valinktx.com/
Contact us
If you are an early-stage SynBio start-up or like to learn more about SynBioVen, we look forward to hearing from you!